Your browser doesn't support javascript.
loading
Rapid inactivation in vitro of SARS-CoV-2 in saliva by black tea and green tea
Eriko Ohgitani; Masaharu Shin-Ya; Masaki Ichitani; Makoto Kobayashi; Takanobu Takihara; Masaya Kawamoto; Hitoshi Kinugasa; Osam Mazda.
Afiliação
  • Eriko Ohgitani; Department of Immunology, Kyoto Prefectural University of Medicine
  • Masaharu Shin-Ya; Department of Immunology, Kyoto Prefectural University of Medicine
  • Masaki Ichitani; Central Research Institute, ITO EN, Ltd.
  • Makoto Kobayashi; Central Research Institute, ITO EN, Ltd.
  • Takanobu Takihara; Central Research Institute, ITO EN, Ltd.
  • Masaya Kawamoto; Department of Immunology, Kyoto Prefectural University of Medicine
  • Hitoshi Kinugasa; Central Research Institute, ITO EN, Ltd.
  • Osam Mazda; Department of Immunology, Kyoto Prefectural University of Medicine
Preprint em Inglês | bioRxiv | ID: ppbiorxiv-424533
Artigo de periódico
Um artigo publicado em periódico científico está disponível e provavelmente é baseado neste preprint, por meio do reconhecimento de similaridade realizado por uma máquina. A confirmação humana ainda está pendente.
Ver artigo de periódico
ABSTRACT
Saliva plays major roles in human-to-human transmission of the SARS-CoV-2. Recently we reported that black, green and oolong tea significantly inactivated SARS-CoV-2 within 1 min. Theaflavin-3,3-di-gallate (TFDG), theasinensin A (TSA) and (-) epigallocatechin gallate (EGCG) were involved in the anti-viral activities. Here we examined how long period is required for the compounds to inactivate the virus. We also assessed whether tea inactivates SARS-CoV-2 diluted in human saliva. Treatment of SARS-CoV-2 with 500 M TFDG or TSA for 10 sec reduced the virus titer to undetectable levels (less than 1/1,000). Black and green tea decreased virus titer to less than 1/100 within 10 sec even in saliva. These findings suggest a possibility that intake of, or gargling with, tea may inactivate SARS-CoV-2 in saliva in infected individuals, which may eventually attenuate spread of COVID-19 within a population, although clinical studies are required to test this hypothesis by determining the intensity and duration of the anti-viral effect of tea in saliva in humans.
Licença
cc_by_nc_nd
Texto completo: Disponível Coleções: Preprints Base de dados: bioRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: bioRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
...